Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katy Langley"'
Publikováno v:
International Journal of Laboratory Hematology. 42:643-649
BACKGROUND The CN-6000 (Sysmex Corp.) is a new haemostasis analyser with blood coagulation, amidolytic, immuno-turbidometric and light transmission aggregometry (LTA) capabilities. Transmitted light is monitored at multiple wavelengths (340, 405, 575
Autor:
Oliver Chapman, William Lester, Debra Ellis, K. Douglas, John-Paul Westwood, Sylvia Benjamin, Tanya Cranfield, Chiara Vendramin, Katy Langley, Tina T. Biss, J. J. van Veen, Karen Vanhoorelbeke, Lynn Manson, Ferras Alwan, Mari Thomas, Nichola Cooper, Quentin A. Hill, Steve Austin, Tina Dutt, Richard Gooding, Amanda Clark, Marie Scully, Vickie McDonald, Henry G. Watson, William Thomas, Keith Sibson
Publikováno v:
Blood. 130:466-471
Immune-mediated thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder caused by antibodies against ADAMTS13. From the United Kingdom TTP registry, we undertook a prospective study investigating the impact of the presenting anti-ADA
Autor:
P Murphy, P Baker, Steve Kitchen, Katy Langley, S MacDonald, Tina Dutt, Vickie McDonald, R Fretwell, Marie Scully, C Hughes, D Singh
Publikováno v:
International journal of laboratory hematology. 40(1)
Introduction Accurate evaluation of ADAMTS13 activity is required for the diagnosis and clinical management of thrombotic microangiopathies, and commercial kits are available for routine laboratory use. Methods Our study compares the results from Tec
Autor:
John-Paul Westwood, Chiara Vendramin, Katy Langley, Mari Thomas, Ferras Alwan, Debra Ellis, Marie Scully
Publikováno v:
Blood. 128:1365-1365
Background: Acute immune-mediated Thrombotic Thrombocytopenic Purpura (TTP) is a life-threatening disorder caused by acquired antibodies to the Von Willebrand factor cleaving protease ADAMTS13. Its prevalence has been estimated at four to thirteen ca
Autor:
Ian J. Mackie, Marie Scully, Katy Langley, Flora Peyvandi, A Chitolie, Samuel J. Machin, Ri Liesner
Publikováno v:
Thrombosis and haemostasis. 109(3)
SummaryADAMTS13 activity assays are sometimes useful in confirming the clinical diagnosis or to distinguish different thrombotic microangiopathies (TMA). We investigated the commonly used clinical assays for ADAMTS13 activity. 159 samples from normal